Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in inflammatory bowel disease.

Chinyu Su1, Gary R Lichtenstein

  • 1Division of Gastroenterology, Department of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Third Floor Ravdin Building, 3400 Spruce Street, Philadelphia, PA 19104-4283, USA.

The Medical Clinics of North America
|January 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic Approaches for Disorders of Gut-Brain Interaction Other Than Medication.

Gastroenterology & hepatology·2026
Same author

Update on the Management of Pregnant Patients With Inflammatory Bowel Disease.

Gastroenterology & hepatology·2026
Same author

Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension Study.

The American journal of gastroenterology·2026
Same author

Nutritional Management of Adult Patients Who Have Crohn's Disease.

Gastroenterology & hepatology·2026
Same author

The Evolving Concept of a Therapeutic Window of Opportunity for Crohn's Disease.

Gastroenterology & hepatology·2026
Same author

Spotlight on the Surveillance of Pouches.

Gastroenterology & hepatology·2026

New targeted therapies show promise for treating inflammatory bowel disease (IBD). Advances in understanding IBD pathogenesis will enable personalized treatment selection in the future.

Area of Science:

  • Gastroenterology and Immunology
  • Molecular Medicine

Background:

  • Inflammatory bowel disease (IBD) treatments are advancing.
  • Targeted therapies, like anti-tumor necrosis factor (anti-TNF) agents, demonstrate significant efficacy.
  • Understanding IBD pathogenesis is crucial for developing new treatments.

Purpose of the Study:

  • To highlight the potential of novel targeted therapies for IBD.
  • To emphasize the role of molecular advancements in developing these therapies.
  • To discuss the future of personalized medicine in IBD treatment.

Main Methods:

  • Review of current literature on IBD therapies.
  • Analysis of the impact of anti-TNF therapy (e.g., infliximab).
  • Discussion of advances in molecular technology and IBD pathogenesis research.

Related Experiment Videos

Main Results:

  • Anti-TNF therapies offer a glimpse into the efficacy of targeted approaches.
  • Molecular technologies facilitate the creation of novel therapeutic agents.
  • Improved understanding of IBD pathogenesis is key to future treatment strategies.

Conclusions:

  • Targeted therapies represent a promising frontier for IBD management.
  • Personalized treatment selection based on patient profiles will become increasingly important.
  • Continued research into IBD pathogenesis is essential for therapeutic innovation.